Multicenter, prospective, single-arm clinical study to investigate the efficacy and safety of Zoladex (Goserelin acetate) 10.8 mg prior to surgery in Chinese premenopausal women with symptomatic uterine fibroids

Objectives To assess the effect and safety of Zoladex (Goserelin acetate) 10.8 mg in patients with uterine fibroids.Methods Fifty-three patients received Goserelin acetate 10.8 mg once and surgery was conducted at 12 weeks ± 7 days after drug injection. All assessments form baseline to week12/before...

詳細記述

書誌詳細

主要な著者:	Yanchun Liang, Ruyu Yang, Yajing Wei, Biqi Huang, Youguo Chen, Xinmei Zhang, Jilong Yao, Guoyun Wang, Hongluan Mao, Honghui Shi, Qing Yang, Junying Tang, Mei Ji, Keqin Hua, Shuzhong Yao
フォーマット:	Artigo
言語:	Inglês
出版事項:	Taylor & Francis Group 2024-12-01
シリーズ:	Gynecological Endocrinology
主題:	Goserelin acetate uterine fibroids efficacy safety
オンライン･アクセス:	https://www.tandfonline.com/doi/10.1080/09513590.2024.2427190
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!